When associated with FXS, autism is caused by the genetic change or mutation in the Fragile X gene—the most common genetic cause of autism. Tune in to learn about emerging research on Fragile X and ASD.
About the speaker:
Randi Hagerman, M.D., is medical director of the UC Davis MIND Institute and director of the Fragile X Research and Treatment Center. She has more than 20 years of experience in the field of neurodevelopmental disorders and is an internationally respected leader in fragile X research including fragile X syndrome, a genetic condition that is the leading cause of inherited intellectual disability and the leading single-gene cause of autism.
Dr. Hagerman, her husband, Dr. Paul Hagerman, and their research team are the discoverers of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), a late-onset neurodegenerative disorder. Randi Hagerman conducts clinical research on individuals with fragile X-associated disorders, including children and adults with fragile X syndrome, adult males with FXTAS, and women with fragile-X related conditions, such as fragile X-associated primary ovarian insufficiency (FXPOI).
Dr. Hagerman also conducts research that bridges the association between autism and fragile X syndrome. Her main area of research is on targeted treatments for neurodevelopmental disorders, including fragile X syndrome, autism, premutation disorders and Angelman syndrome.
Learn about emerging research exploring specific gene-environment interactions that may increase risk for ASD and to understand their mechanisms of action. Handouts are available online HERE
Free certificates of participation are available upon successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-test/start/?quiz=yqt58b6db9137142 Published: 03/01/2017 Richard Frye, M.D., Ph.D. is the Director of Autism Research and Associate Professor